Find uplifting stories about heroes, innovations, and solutions
1256 results for "ebola vaccine"
The Democratic Republic of the Congo just received 70,000 Ebola vaccine doses to combat a rare strain of the virus. Half will protect frontline workers while 20,000 will help scientists learn if the existing vaccine works against this different Ebola type.
Scientists are fast-tracking three promising vaccines to fight the Ebola outbreak in Congo and Uganda, with clinical trials starting within months. New funding of $62 million is speeding up development of the first vaccines specifically designed for the Bundibugyo virus strain.
The Democratic Republic of Congo has launched a massive vaccination campaign for frontline health workers battling one of the deadliest Ebola outbreaks in history. More than 50,000 vaccine doses are protecting those risking their lives to save others.
A new Ebola vaccine developed in just eight weeks has been given to its first human volunteer, with 600,000 doses already manufactured and ready to deploy. The experimental vaccine targets a deadly Ebola strain currently spreading in the Democratic Republic of Congo.
Scientists are racing to test vaccines that could help stop the second-largest Ebola outbreak in history. Clinical trials launching soon in the Democratic Republic of Congo offer new hope.
Scientists are racing to test whether an existing Ebola vaccine can protect people from the Bundibugyo virus outbreak in the Democratic Republic of Congo. New animal studies show the vaccine could work, offering hope as researchers prepare human trials.
The Democratic Republic of Congo is receiving 70,000 doses of proven Ebola vaccine as the world rallies to help fight the outbreak. With $13 million in funding and expanded treatment capacity, health teams are turning the tide on the epidemic.
Scientists say an existing Ebola vaccine could protect people from a rapidly spreading outbreak in Congo that's killed nearly 1,000 people. New research is pushing health officials to test the vaccine now rather than wait months for new ones.
The world is racing to help the Democratic Republic of the Congo fight its fastest-moving Ebola outbreak in history, with the first of 70,000 vaccine doses arriving Friday. While health workers face enormous challenges, the international community is stepping up with unprecedented speed.
Scientists are racing to test whether an existing Ebola vaccine could save thousands of lives in the Democratic Republic of Congo's deadliest outbreak in years. Early animal studies suggest the vaccine might work against a different strain than it was designed for.
Scientists just gave the first human dose of a vaccine designed specifically for the Bundibugyo Ebola strain—a breakthrough that could save thousands of lives in the Democratic Republic of Congo, where over 1,000 people have already died. The vaccine went from concept to human trial in just eight weeks.
A $60 million global health initiative is rushing three new vaccine candidates to combat a deadly Ebola outbreak in the Democratic Republic of Congo. The same mRNA technology that helped end the COVID-19 pandemic could now save lives in Central Africa.
Three promising vaccine candidates just received $60 million in emergency funding to combat the Bundibugyo Ebola strain spreading in Central Africa. For the first time, doctors will also test a prevention pill that could stop the disease before it starts.
The Democratic Republic of Congo is receiving 70,000 Ebola vaccine doses to protect frontline health workers battling the country's deadliest outbreak on record. Global health partners are stepping up to support communities facing both disease and conflict.
Moderna has launched human trials for the first vaccine targeting the Bundibugyo Ebola strain devastating the Democratic Republic of Congo. Using proven mRNA technology from COVID-19, the company is racing to create protection where none currently exists.
Scientists are fast-tracking three promising vaccines to fight a rare Ebola species that's killed nearly 250 people in Central Africa. Using lessons from COVID, researchers say they're working with urgency to protect communities before the outbreak grows worse.
A deadly disease that once terrorized West Africa is about to get much easier to stop. A new $30 million project will make the Ebola vaccine cheaper and possible to store in regular refrigerators, bringing lifesaving protection to remote communities across Africa.
Health workers are fighting to protect children in the Democratic Republic of Congo as a promising vaccine shows early signs it could help stop a deadly Ebola outbreak. After losing more than 300 young lives, a breakthrough in animal studies is opening the door to new protection.
A new partnership aims to make the Ebola vaccine storable in regular refrigerators instead of ultra-cold freezers, solving a major problem for remote African communities. The $30 million project could also cut costs dramatically and increase production during outbreaks.
Liberia is getting ready to vaccinate healthcare workers at its borders and ports of entry against Ebola, strengthening defenses after learning hard lessons from past outbreaks. The move protects those on the frontlines while the country watches a neighboring outbreak closely.
Showing 20 of 1256